![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 29, 25976-25982, July 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 22, 2002, and in revised form, May 9, 2002
The bacterial HslVU ATP-dependent
protease is a homolog of the eukaryotic 26 S proteasome. HslU ATPase
forms a hexameric ring, and HslV peptidase is a dodecamer consisting of
two stacked hexameric rings. In HslVU complex, the HslU and HslV
central pores are aligned, and the proteolytic active sites are
sequestered in an internal chamber of HslV, with access to this chamber
restricted to small axial pores. Here we show that the C-terminal tails
of HslU play a critical role in the interaction with and activation of
HslV peptidase. A synthetic tail peptide of 10 amino acids could
replace HslU in supporting the HslV-mediated hydrolysis of unfolded
polypeptide substrates such as ATP-dependent proteolysis plays an essential role in
controlling the levels of key regulatory proteins and in the
elimination of abnormal polypeptides (1, 2). These tasks are carried out by architecturally related ATP-dependent proteases such
as the 26 S proteasome in eukaryotes (3, 4) and the ClpAP, ClpXP, and
HslVU (ClpQY) proteases in archea and eubacteria (5-7). The 26 S
proteasome consists of the 20 S proteasome, which forms a proteolytic
core, and the 19 S regulatory complex harboring multiple ATPase
activities (8, 9). The barrel-shaped 20 S proteasome is composed of
The bacterial HslVU protease is a homolog of the eukaryotic 26 S
proteasome (10, 11). HslVU in Escherichia coli is the product of the hslVU operon, which encodes two heat shock
proteins, the HslV peptidase and HslU ATPase (12). HslV forms a
dodecamer of two back-to-back stacked hexameric rings (13). HslU forms a hexameric ring and binds to either one or both HslV ends (14, 15).
The cod operon in Bacillus subtilis encodes the
CodW and CodX proteins (in addition to CodV and CodY), both of which
display more than 50% identity in their amino acid sequences with HslV and HslU in E. coli, respectively (16). Recently, we have
demonstrated that CodW provides the peptidase activity, whereas CodX
harbors the ATPase activity, both of which can function together as a new type of two-component ATP-dependent protease (17).
Remarkably, CodW uses its N-terminal Ser hydroxyl group as the
catalytic nucleophile, unlike HslV in E. coli and certain
The HslU ATPase is a member of the Clp/Hsp100 family of molecular
chaperones (20). Functions that have been attributed to this family
member include facilitating the degradation of target proteins by
cognate proteases (21-23) as well as disassembly of oligomeric protein
complexes (22, 24). HslU supports the HslV-mediated degradation of
SulA, an inhibitor protein of E. coli cell division, but by
itself can also function in prevention of aggregation of the inhibitor
protein (23, 25). Among these family members, ClpA and ClpX target
ssrA-tagged polypeptides to the ClpP peptidase for degradation (21) but
by themselves can also function in disassembly of oligomeric proteins,
such as the plasmid P1 RepA replication initiator and the DNA-bound MuA
transposase, respectively (22, 24). Moreover, recent studies using
ssrA-tagged green fluorescent protein as a substrate have shown that
ClpA and ClpX unfold green fluorescent protein in an
ATP-dependent process and translocate it into the catalytic
compartment of the ClpP protease (26, 27).
The crystal structures of peptidase components such as ClpP and HslV
reveal that the peptidases consist of two doughnut-shaped rings within
which the proteolytic active sites are sequestered in an inner chamber,
with access to this chamber restricted to small axial pores (13, 28).
The diameters of these pores are so small that only a single strand of
polypeptide can be threaded through (13, 29). Therefore, native protein
substrates have to be unfolded by an associated ATPase and actively
translocated into the cognate peptidase for degradation (30-32). This
mechanism requires the specific docking of the ATPase with the
peptidase. Recently, it has been demonstrated that a tripeptide, IGF,
in E. coli ClpX is essential for ClpP recognition and that
mutations in this IGF sequence disrupt ClpXP complex formation and
prevent protease function (33). On the other hand, HslU, which does not
have the conserved IGF motif, does not bind ClpP but interacts with
HslV. These findings imply that other motif in HslU ATPase may exist
and mediate the interaction with and activation of HslV through
different mechanisms.
To date, a number of crystal and solution structures of HslVU have been
reported (34-37). We have recently characterized four distinct HslU
conformational states (in complex with HslV) and determined the
nucleotide-dependent conformational changes within them, especially including a conformational change of its C
terminus (38). The highly conserved HslU C terminus is inserted at an HslV-HslV interface when ATP is bound; otherwise it is buried at the
HslU-HslU interface (35, 38, 39). Therefore, we have suggested that the
insertion of HslU C-terminal tails into pockets at the HslV-HslV
interface in the ATP-bound state might cause the opening of the central
pore of HslV peptidase for the access of unfolded polypeptide
substrates into the proteolytic chamber. In the present studies, we
provide biochemical evidence showing that the HslU C terminus is
essential for its interaction with HslV and for activation of the
peptidase. We demonstrate as well that the C-terminal tails of CodX
ATPase are also involved in the activation of CodW peptidase.
Materials--
All reagents for PCR, including Taq
polymerase and restriction endonuclease, were purchased from Takara
(Shiga, Japan). Peptide substrates were obtained from Bachem
Feinchmikalien AG (Bubendorf, Switzerland). Synthetic peptides
ADEDLSRFIL (HslU tail sequence), KNKDLSQFIL (CodX tail sequence), and
SLDIARFKNE (scrambled tail sequence) were purchased from AnyGen
(Kwangju, Korea). All other reagents were purchased from Sigma, unless
otherwise indicated. HslV, HslU, CodW, CodX, and their mutant forms
were purified as described previously (17, 40).
Mutagenesis--
Site-directed mutagenesis was carried out using
the QuikChange Site-Directed Mutagenesis Kit (Stratagene) with
pGEM-T/HslVU as the templates. The PCR reactions were carried out using
mutagenic primers, which were designed to replace the codons for
Ser439, Asp437, or Ala434 by a stop
codon (TAA) for generating the HslU deletion mutants lacking 5 (HslU/ Assays--
Peptide hydrolysis was assayed as described
previously using N-carbobenzoxy
(Cbz)1-Gly-Gly-Leu-7-amido-4-methylcoumarin
(AMC) as a substrate (40). Reaction mixtures (0.1 ml) contained the
peptide substrate (0.1 mM) and appropriate amounts of the
purified HslV and HslU or its mutant forms in 0.1 M HEPES
buffer (pH 8) containing 10 mM MgCl2, 1 mM ATP, 1 mM dithiothreitol, and 1 mM EDTA. Incubations were performed for various periods of
time at 37 °C and were stopped by adding 0.1 ml of 1% (w/v) SDS and
0.8 ml of 0.1 M sodium borate, pH 9.1. The release of AMC
was then measured using a fluorometer. ATP hydrolysis was assayed by
incubating similar reaction mixtures at 37 °C but in the absence of
the peptide. After incubation, 0.2 ml of 1% SDS was added to the
samples, and the amount of phosphate released was determined as
described (41).
For assaying protein degradation, reaction mixtures (0.1 ml) contained
5 µg of Cross-linking Analysis--
Aliquots (4 µg each) of the
purified HslU or HslV protein or their mixtures were incubated in 0.1 M HEPES buffer (pH 8) containing 10 mM
MgCl2, 1 mM ATP Interaction of HslU C Terminus with HslV--
The crystal and
solution structures of HslVU complex (35, 38, 39) have revealed that
the HslU C terminus interacts with the binding pocket of HslV. Notably,
Leu443 (C-terminal carboxylate), Arg440, and
Asp437 in the C-terminal tails of HslU ATPase are involved
in a direct interaction with Lys28, Glu61, and
Lys73 of HslV peptidase, respectively, by forming salt
bridges (Fig. 1A). In
addition, Leu438 and Ile442 in the C-terminal
tails of HslU form a hydrophobic core with Val72,
Val76, and Val112 of the adjacent HslV.
Moreover, these amino acid residues in the C-terminal sequence of HslU
are highly conserved in various microorganisms (Fig.
2), implying the ubiquitous function of
the C-terminal tail region of HslU family in the interaction with and
thus in the activation of cognate peptidases.
Activation of HslV Peptidase by HslU Tail Peptide--
To
determine whether the C-terminal tails of HslU indeed play an essential
role in HslVU complex formation and thus in the activation of HslV
peptidase, a peptide corresponding to the C-terminal 10 residues of
HslU was synthesized and referred to as C10HslU.
Site-directed mutagenesis was also performed to serially delete the
amino acid residues in the C-terminal tail region of HslU (Fig.
3A). The mutant proteins
(HslU/
First, we examined whether C10HslU alone could support the
hydrolysis of Cbz-Gly-Gly-Leu-AMC by HslV. As shown in Fig.
4A, the peptidase activity of
HslV was dramatically stimulated by C10HslU. HslV (0.1 µg) in the presence of 20 µg of C10HslU hydrolyzed the
peptide substrate at about one-half the rate seen with 0.4 µg of
HslU. Moreover, the stimulatory effect of C10HslU was
dependent on its concentration (Fig. 4B). On the other hand, a control peptide with scrambled sequence showed little or no effect
(data not shown). These results indicate that C10HslU can
replace HslU in the activation of the HslV-mediated peptide hydrolysis,
although its apparent affinity to HslV is much lower than that of
HslU.
We then examined the effect of C10HslU on the degradation
of protein substrates by HslV.
SulA is a cell division inhibitor protein in E. coli encoded
by the SOS-inducible sulA gene, which is also called
sfiA (47). We have previously shown that the inhibitor
protein fused to the C terminus of maltose-binding protein (MBP) is
degraded by HslVU under both in vitro and in vivo
conditions. We have also shown that ATP hydrolysis by HslU is essential
for SulA degradation by HslV (23). To determine whether
C10HslU can replace HslU in supporting SulA degradation by
HslV, MBP-SulA was incubated with the peptidase in the absence and
presence of C10HslU. Little or no degradation of MBP-SulA
was observed unless both HslU and ATP were present (Fig.
5B). Thus, it appears that unfolding of SulA by HslU ATPase
is essential for degradation of the inhibitor protein, in addition to
the opening of the central pore of HslV.
Effects of HslU C-terminal Deletion Mutations--
To define
further the involvement of the C-terminal tails of HslU in the
activation of HslV peptidase, we examined the effects of HslU deletion
mutations in the tail region on the proteolytic activity of HslV.
HslU/
HslU alone hydrolyzes ATP, and its ATPase activity is enhanced
severalfold upon interaction with HslV (40). To determine the effect of
the deletion mutations in the C-terminal tail region of HslU on the
ATPase activity, ATP hydrolysis was assayed in the absence and presence
of HslV. Without HslV, HslU/
To confirm whether the C-terminal tails of HslU are indeed essential
for its interaction with HslV, cross-linking analysis was performed by
incubating each of the C-terminal deletion mutants with glutaraldehyde
in the absence and presence of HslV. Fig. 7A shows that HslU/ Activation of CodW Peptidase by CodX C-terminal
Tails--
Recently, we have shown that CodWX in B. subtilis, which is a homolog of HslVU in E. coli, is a
new type of ATP-dependent protease, harboring the Ser
active site for proteolysis at the N terminus of CodW (17). Because the
structure of CodWX has not been determined yet, modeling on the binding
pocket of CodW peptidase for the C terminus of CodX ATPase was
performed on the basis of the structure of HslVU complex. In this
modeling (Fig. 1B), CodX has Gln464 at the
position corresponding to Arg440 of HslU, which forms a
salt bridge with Glu61 in HslV (see Fig. 1A).
Therefore, the Gln residue in the C-terminal tails of CodX is
unlikely to form a salt bridge with Glu67 in CodW, which
corresponds to Glu61 in HslV. Moreover, CodW has
Lys78 at the position corresponding to Val72 in
HslV, which forms a hydrophobic core with Leu438 and
Ile442 in the C-terminal tails of HslU (Leu462
and Ile466 in CodX) as well as with Val76 and
Val112 in the same HslV polypeptide (Val82 and
Val118 in CodW). Thus, the hydrophobic interaction around
the C-terminal tail region of CodX in CodWX complex would not be as
strong as that in HslVU. This modeling implies that CodWX would be a
weaker protease than HslVU. To test this possibility, we compared the activity of CodWX with that of HslVU by incubation of the same amounts
of the enzymes for the same period with Cbz-Gly-Gly-Leu-AMC or
Based on these findings, we intended to generate an artificial CodWX
protease with improved activity by replacing Gln464 of CodX
by Arg and Lys78 of CodW by Val, thus allowing the
substituted amino acids to form a salt bridge and hydrophobic
interaction, respectively. The mutant proteins, referred to as
CodX/Q464R and CodW/K78V, were purified to apparent homogeneity as
described (see Fig. 3C) (17). Table
I shows that the peptidase activity of
CodWX increased by about 1.5- and 4.7-fold upon substitution of
Gln464 of CodX by Arg and Lys78 of CodW by Val,
respectively. Furthermore, when CodW/K78V and CodX/Q464R were incubated
together, the peptidase activity was increased further to about
7.5-fold. Under similar assay conditions, the ATPase activity was not
significantly changed upon the mutations. These results strongly
suggest that the activation mechanism involving the C-terminal tail of
ATPase is also functional in CodWX complex.
Whereas HslV itself is a weak peptidase, CodW cannot cleave
Cbz-Gly-Gly-Leu-AMC without CodX. Moreover, the ATPase activity of CodX
is essential for activation of CodW
peptidase,2 whereas ATP
binding, but not its hydrolysis by HslU, is required for degradation of
peptides by HslV (48). To examine whether the CodX C-terminal tail
peptide can activate CodW peptidase as C10HslU did, a
peptide corresponding to the C-terminal 10 residues of CodX was
synthesized and referred to as C10CodX. Upon incubation
with C10CodX, we could clearly detect the peptidase
activity of CodW. Furthermore, CodW/K78V exhibited an ~6-fold higher
activity than CodW in the presence of the same amount of
C10CodX. However, the activity of CodW/K78V even in the
presence of excess C10CodX was less than 5% of that seen
with CodX and ATP (data not shown). These results suggest that other
mechanism(s) for CodX ATPase-mediated activation of CodW peptidase
should exist in addition to that involving the interaction of the
C-terminal tails of CodX with the binding pocket of CodW.
Recent structural studies on HslVU complex as well as on
uncomplexed HslU have shown that in the dADP-bound state the C-terminal tail of HslU, which forms a short loop and helix, is buried
inside a hydrophobic pocket at the HslU-HslU interface (35, 38, 39). When ATP is bound, it distends and binds at an HslV-HslV interface. This conformational change, which is likely to cycle upon ATP hydrolysis, reflects the role of the HslU C-terminal tails as a
molecular switch for binding and functional interaction with HslV.
Lines of biochemical evidence provided in the present study indicate
that the C-terminal tails of HslU ATPase acts as a molecular switch for
the assembly of HslVU complex and for the activation of HslV peptidase.
First, a synthetic peptide corresponding to the C-terminal 10 residues
of HslU, C10HslU, could activate the peptidase activity of
HslV. Moreover, C10HslU could also support the hydrolysis
of unfolded protein substrates such as Second, a mutant form of HslU, HslU/ Finally, a catalytically improved CodWX protease could be engineered by
introduction of a salt bridge and hydrophobic interaction between the
C-terminal region of CodX ATPase and the binding pocket of CodW
peptidase, which were not present in the authentic CodWX complex,
unlike HslVU, due to the difference in the sequences of the binding
region. Moreover, a synthetic peptide corresponding to the C-terminal
10 residues of CodX, C10CodX, could activate the peptidase
activity of CodW, which by itself is inactive, although the
extent of the activation by C10CodX was far lower than that
by CodX. These results further support the idea that the activation
mechanism involves the interaction of the C-terminal tail of HslU with
the binding pocket of HslV.
In certain structures of HslVU complex, HslV is in contact with HslU
through the intermediate (I) domain, and the pores of HslV and
HslU are not aligned with each other (34). However, this structure
appears not feasible, because the activation of HslV requires its
binding with the C-terminal tail region of HslU located opposite the I
domain and because the deletion of seven amino acids from the C
terminus prevents the formation of HslVU complex. Thus, the HslVU
structure, in which HslV is contacted by HslU through the N and C
domains, appears relevant.
Crystallographic and biochemical analyses have recently demonstrated
that the eukaryotic 20 S proteasome is a gated protease and that
opening of the gate can be achieved by binding of PA26 and 19 S
regulatory complex (49-51). PA26 (also called 11 S regulator, REG, and
PA28) is a heptamer that stimulates the peptidase activities of the 20 S proteasome (52-55). In the latent state of the 20 S proteasome,
substrate entry into the inner proteolytic chamber is blocked by the
gate formed by the N-terminal tails of certain *
This work was supported by grants the from Korea Research
Foundation, Korea Science and Engineering Foundation (through Research Center for Proteinacious Materials), and the Korea Ministry of Science
and Technology (Grant 01J000001500).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipients of a fellowship from the BK21 Program.
**
To whom correspondence should be addressed: School of Biological
Sciences, Seoul National University, Seoul 151-742, Korea. Tel.:
82-2-880-6693; Fax: 82-2-871-9193; E-mail: chchung@snu.ac.kr.
Published, JBC Papers in Press, May 14, 2002, DOI 10.1074/jbc.M202793200
2
M. S. Kang, unpublished observation.
The abbreviations used are:
Cbz, N-carbobenzoxy;
AMC, amido-4-methylcoumarin;
ATP
The C-terminal Tails of HslU ATPase Act as a Molecular
Switch for Activation of HslV Peptidase*
,
,
§,
§,
§,
, and
**
National Research Laboratory of
Protein Biochemistry, School of Biological Sciences, Seoul National
University, Seoul 151-742, Korea, the ¶ Department of Molecular
Biophysics and Biochemistry, Yale University, New Haven,
Connecticut 06520, and the
Department of Life Science,
Kwangju Institute of Science and Technology, Kwangju 500-712, Korea
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-casein, as well as of small
peptides, suggesting that the HslU C terminus is involved in the
opening of the HslV pore for substrate entry. Moreover, deletion of 7 amino acids from the C terminus prevented the ability of HslU to form
an HslVU complex with HslV. In addition, deletion of the C-terminal 10 residues prevented the formation of an HslU hexamer, indicating that
the C terminus is required for HslU oligomerization. These results
suggest that the HslU C-terminal tails act as a molecular switch for
the assembly of HslVU complex and the activation of HslV peptidase.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
- and
-type subunits. The
-type subunits, which are
proteolytically inactive, form the outer ring, and the
-type
subunits, which contain the active sites, form inner rings of the complex.
-type proteasome subunits, which have N-terminal Thr as an active
site residue (18, 19).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
C5), 7 (HslU/
C7), or 10 amino acid residues (HslU/
C10)
from its C terminus, respectively. The resulting plasmids were
transformed into MC1000H carrying
hslVU::kan (23). Substitutions of the
nucleotides by mutagenesis were verified by DNA sequencing.
-casein or MBP-SulA, 0.5 µg of HslV, and 2 µg of HslU
or its mutant forms in 0.1 M HEPES buffer (pH 8) containing 10 mM MgCl2, 1 mM ATP, 1 mM dithiothreitol, and 1 mM EDTA. Incubations were carried out for 2 h at 37 °C and stopped by adding 30 µl of 0.75 M Tris-HCl (pH 6.8) containing 7.5% SDS and 10%
(v/v) 2-mercaptoethanol. They were then subjected to SDS-PAGE on 13% slab gels (42). The gels were stained with Coomassie Blue R-250. Proteins were quantified by their absorbance at 280 nm or by the method
of Bradford (43) using bovine serum albumin as a standard.
S, 1 mM
dithiothreitol, 1 mM EDTA, and 0.4% (v/v) glutaraldehyde
in a total volume of 0.1 ml. After incubation for 20 min at 37 °C,
the samples were mixed with 30 µl of 0.75 M Tris-HCl (pH
6.8) containing 7.5% SDS and 10% 2-mercaptoethanol. They were then
subjected to SDS-PAGE on 4-8% gradient slab gels (42). Proteins in
the gels were visualized by silver staining.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (70K):
[in a new window]
Fig. 1.
Binding pocket of HslV for the HslU C
terminus (A) and a modeling of the corresponding
regions in CodW and CodX (B). The salt bridges
are indicated by dotted lines. The amino acids involved in
hydrophobic interaction are shown by circles. This figure
was prepared with MOLMOL (57).

View larger version (63K):
[in a new window]
Fig. 2.
Amino acid sequences of the C-terminal tail
region of HslU family members. The HslU tail sequence conservation
is shown in gray scale from the most (dark) to
least (white) conserved. At the top, the amino
acid residues that may form salt bridges with those in cognate
peptidases are marked by asterisks. The amino acids that may
form hydrophobic cores are indicated by diamonds. The amino
acid sequence data were obtained from the Swiss Protein,
GenBankTM, and EMBL databases.
C5, HslU/
C7, and HslU/
C10) were purified to apparent
homogeneity (Fig. 3C). Although we attempted to generate
other HslU mutants with different C-terminal lengths (e.g.
HslU/
C1), they were recovered as insoluble precipitates (data not
shown).

View larger version (26K):
[in a new window]
Fig. 3.
Amino acid sequences subjected to mutagenesis
and SDS-PAGE of purified HslU, CodX, CodW, and their mutant forms.
A, C10HslU represents the synthetic peptide
corresponding to the C-terminal 10 residues of HslU. The C-terminal
residues of HslU were serially deleted, and the resulting mutant forms
were named HslU/
C5, HslU/
C7, and HslU/
C10. B, the
bold letters indicate the amino acid residues that form a
hydrophobic core with Leu462 and Ile466 in CodX
(see Fig. 1B). Gln464 in CodX and
Lys78 in CodW were replaced by Arg and Val by site-directed
mutagenesis, and the resulting mutant forms were named CodX/Q464R and
CodW/K78V, respectively. C, purified HslU, CodX, CodW, and
their mutant forms were subjected to SDS-PAGE on 13% slab gels
followed by staining with Coomassie Blue R-250. Each lane
contained 3 µg of protein.

View larger version (13K):
[in a new window]
Fig. 4.
Effect of C10HslU on
peptide hydrolysis by HslV. A, peptide hydrolysis was
assayed by incubating 0.1 µg of HslV, 0.1 mM
Cbz-Gly-Gly-Leu-AMC, and 1 mM ATP in the absence (
) and
presence of 20 µg of C10HslU (
) or with 0.4 µg of
HslU (
) for various periods of time at 37 °C. B,
assays were also performed as described above except with incubation
for 10 min with 0.1 µg of HslV and increasing amounts of
C10HslU.
-Casein was incubated with HslV in
the absence and presence of C10HslU for 2 h at
37 °C. After incubation, the samples were subjected to SDS-PAGE
followed by staining with Coomassie Blue R-250. As previously reported
(44), HslV efficiently degraded
-casein in the presence of HslU but
much less efficiently in its absence (Fig.
5A). Remarkably,
C10HslU also supported the casein degradation by HslV
nearly as well as HslU did. Similar results were obtained when insulin
B-chain was used as a substrate (data not shown). The casein milk
proteins, including
-casein, are known as natively unfolded proteins
with nonregular structures (45, 46). These results suggest that C10HslU interacts with HslV and causes the opening of its
central pore for the access of unfolded polypeptide substrates as well
as small peptides into the proteolytic chamber.

View larger version (63K):
[in a new window]
Fig. 5.
Effect of C10HslU on protein
degradation by HslV.
-Casein (A) or MBP-SulA
(B) was incubated with HslV (0.5 µg) in the absence and
presence of C10HslU (20 µg) or with HslU (2 µg) for
2 h at 37 °C. After incubation, the samples were subjected to
SDS-PAGE as described under "Experimental Procedures." The
arrowhead indicates the degradation product from MBP-SulA.
The bands corresponding to
-casein and MBP-SulA were scanned using a
densitometer, and their intensities were expressed as 100%; the
other bands were expressed relative to the values shown at the
bottom of the gels.
C5 was capable of supporting the hydrolysis of
Cbz-Gly-Gly-Leu-AMC by HslV ~40% as well as the wild-type HslU (Fig.
6A). In contrast, neither
HslU/
C7 nor HslU/
C10 could support the peptidase activity of
HslV. Similar to the peptide hydrolysis, HslU/
C5 but not HslU/
C7
or HslU/
C10 could support the HslV-mediated degradation of protein
substrates, including
-casein and MBP-SulA, about 40% as well as
the wild-type HslU (data not shown). These results suggest that the
shortening of C-terminal tail length (i.e. serial
elimination of the amino acids that form salt bridges and hydrophobic
interaction) reduces the affinity of HslU to the binding pocket of
HslV, resulting in a gradual loss of its potential to activate the
peptidase.

View larger version (20K):
[in a new window]
Fig. 6.
Effects of deletion mutations in the
C-terminal tail region of HslU on peptide hydrolysis by HslV and on its
ATPase activity. A, peptide hydrolysis was assayed by
incubating 0.1 µg of HslV, 0.1 mM Cbz-Gly-Gly-Leu-AMC, 1 mM ATP, and increasing amounts of the wild-type HslU (
),
HslU/
C5 (
), HslU/
C7 (
), or HslU/
C10 (
) for 10 min at
37 °C. B, ATP hydrolysis was assayed by incubating 1 mM ATP and 1 µg of the wild-type HslU or its mutant forms
in the absence (gray bars) and presence of 1 µg of HslV
(black bars). After incubation for 1 h at 37 °C, the
phosphates released were then determined as described under
"Experimental Procedures."
C5 and HslU/
C7 cleaved ATP nearly as
well as the wild-type HslU (Fig. 6B), indicating that
deletion of C-terminal tails up to seven amino acids does not influence
on the ability of HslU in ATP binding and its hydrolysis. However, the
ATPase activity of HslU/
C7 was not stimulated at all by HslV. In
addition, the extent of HslV-activated ATPase activity of HslU/
C5
was reduced to about one-half of that seen with the wild-type HslU.
These results suggest that HslU/
C5 but not HslU/
C7 is capable of
interaction with HslV, albeit with a lower affinity than the wild-type
HslU. In contrast, little or no ATPase activity was observed with
HslU/
C10 whether or not HslV was present, suggesting that
HslU/
C10 is unable to bind ATP or to form a hexameric complex, which
is essential for ATP hydrolysis.
C5 and
HslU/
C7 but not HslU/
C10 could oligomerize into a hexameric form
in the absence of HslV. However, HslU/
C7 could not form a HslVU
complex, unlike the wild-type HslU and HslU/
C5 (Fig. 7B).
In addition, the extent of HslVU complex formation by HslU/
C5 was
significantly lower than that by the wild-type HslU. On the other hand,
HslU/
C10, which is unable to oligomerize into a hexamer, could
not form a HslVU complex with HslV. These results indicate that
the C-terminal tails of HslU play a key role not only in its
oligomerization but also in HslVU complex formation with HslV.

View larger version (85K):
[in a new window]
Fig. 7.
Effects of deletion mutations in the
C-terminal tail region of HslU on its oligomerization and complex
formation with HslV. Cross-linking analysis was performed by
incubating 4 µg of the wild-type HslU (lane a), HslU/
C5
(lane b), HslU/
C7 (lane c), or HslU/
C10
(lane d) with 1 mM ATP
S and 0.4%
glutaraldehyde in the absence (A) and presence of 4 µg of
HslV (B). After incubation for 20 min at 37 °C, the
samples were subjected to SDS-PAGE followed by silver staining.
-casein. CodWX was found to degrade both substrates only about 3-4% as well as HslVU (data not shown).
Effects of mutations in putative interacting regions in CodW and CodX
on peptide and ATP hydrolysis
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-casein nearly as well as
HslU. These results clearly suggest that the binding of
C10HslU to the HslV-HslV interface leads to opening of the
HslV pore for the entry of unfolded polypeptides as well as small
peptides into its proteolytic chamber. These results also suggest that ATP hydrolysis is not essential for opening of the HslV pore and that
the catalytic activation reflects a simple opening of the pore.
However, C10HslU was unable to support the degradation of
SulA, indicating that ATP hydrolysis is required for unfolding of
native folded proteins by HslU prior to their access to the HslV pore.
C7 lacking the C-terminal seven
amino acids, could not form a HslVU complex with HslV, indicating that
the tail region provides a critical motif for interaction with HslV. In
the C-terminal tail region of HslU, the last seven amino acids are
highly conserved among the HslU family members in various
microorganisms (see Fig. 2). Moreover, most of these residues are
involved in the formation of salt bridges and a hydrophobic core with
the adjacent amino acids in HslV (35, 39). Noteworthy is the finding
that HslU/
C10 lacking the C-terminal 10 amino acids is unable to
form a hexamer, unlike HslU/
C7 or the wild-type HslU. Structural
analysis of HslVU complex has shown that Glu436 in HslU
forms a salt bridge with Lys314 in adjacent HslU
subunit (39), implying that the Glu residue may play a critical
role in oligomerization of HslU although we cannot exclude the
possibility that two adjacent amino acids (i.e. Ala434 and Asp435) in HslU are also involved in
the oligomer formation. Thus, the C-terminal tails of HslU appear to
play an essential role in the assembly of HslVU complex with HslV as
well as the oligomerization of itself.
-subunits that reside
in the outer ring (49, 56). Groll et al. (49) have shown
that deletion of the tails opens the gate for substrate entry and that
exogenously added N-terminal tail peptide masks the gate, thus
preventing proteolysis. Whitby et al. (50) have revealed
that the binding affinity provided by insertion of the PA26 C-terminal
tails into pockets of 20 S proteasome in the complex structure is used
to open the gate. In analogy, the insertion of HslU C-terminal tails
into the HslV-HslV interface in the ATP-bound state causes the HslU and
HslV rings to twist around their mutual 6-fold axis, opening the HslV
pore in a "twist-and-open" mechanism (38). Fig.
8 shows a schematic model for the opening of the HslV pore upon interaction of a HslU tail peptide with HslV.
Thus, it is interesting that both bacterial and eukaryotic proteasomes
share a similar activation mechanism using the C-terminal tails of
their regulatory components.

View larger version (27K):
[in a new window]
Fig. 8.
Schematic model for opening of the HslV pore
upon binding of the HslU tail peptide.
![]()
FOOTNOTES
![]()
ABBREVIATIONS
S, adenosine 5'-O-(thiotriphosphate);
MBP, maltose-binding
protein.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Goldberg, A. L.
(1992)
Eur. J. Biochem.
203,
9-23[Medline]
[Order article via Infotrieve]
2.
Gottesman, S.,
and Maurizi, M. R.
(1992)
Microbiol. Rev.
56,
592-621 3.
Baumeister, W.,
Walz, J.,
Zuhl, F.,
and Seemüller, E.
(1998)
Cell
92,
367-380[CrossRef][Medline]
[Order article via Infotrieve]
4.
Ciechanover, A.,
and Schwartz, A. L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2727-2730 5.
Chung, C. H.
(1993)
Science
262,
372-374 6.
Gottesman, S.
(1996)
Annu. Rev. Genet.
30,
465-506[CrossRef][Medline]
[Order article via Infotrieve]
7.
Chung, C. H.,
Yoo, S. J.,
Seol, J. H.,
and Kang, M. S.
(1997)
Biochem. Biophys. Res. Commun.
241,
613-616[Medline]
[Order article via Infotrieve]
8.
Ciechanover, A.
(1994)
Cell
79,
13-21[CrossRef][Medline]
[Order article via Infotrieve]
9.
Coux, O.,
Tanaka, K.,
and Goldberg, A. L.
(1996)
Annu. Rev. Biochem.
65,
801-847[CrossRef][Medline]
[Order article via Infotrieve]
10.
Seemüller, E.,
Lupas, A.,
Stock, D.,
Löwe, J.,
Huber, R.,
and Baumeister, W.
(1995)
Science
268,
579-582 11.
DeMot, R.,
Nagy, I.,
Walz, J.,
and Baumeister, W.
(1999)
Trends Microbiol.
7,
88-92[CrossRef][Medline]
[Order article via Infotrieve]
12.
Chuang, S. E.,
Burland, V.,
Plunkett, G.,
Daniels, D. L.,
and Blattner, F. R.
(1993)
Gene
134,
1-6[CrossRef][Medline]
[Order article via Infotrieve]
13.
Bochtler, M.,
Ditzel, L.,
Groll, M.,
and Huber, R.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
6070-6074 14.
Rohrwild, M.,
Pfeifer, G.,
Santarius, U.,
Müller, S. A.,
Huang, H. C.,
Engel, A.,
Baumeister, W.,
and Goldberg, A. L.
(1997)
Nat. Struct. Biol.
4,
133-139[CrossRef][Medline]
[Order article via Infotrieve]
15.
Ishikawa, T.,
Maurizi, M. R.,
Belnap, D.,
and Steven, A. C.
(2000)
Nature
408,
667-668[Medline]
[Order article via Infotrieve]
16.
Slack, F. J.,
Serror, P.,
Joyce, E.,
and Sonenshein, A. L.
(1995)
Mol. Microbiol.
15,
689-702[Medline]
[Order article via Infotrieve]
17.
Kang, M. S.,
Lim, B. K.,
Seong, I. S.,
Seol, J. H.,
Tanahashi, N.,
Tanaka, K.,
and Chung, C. H.
(2001)
EMBO J.
20,
734-742[CrossRef][Medline]
[Order article via Infotrieve]
18.
Seemüller, E.,
Lupas, A.,
and Baumeister, W.
(1996)
Nature
382,
468-470[CrossRef][Medline]
[Order article via Infotrieve]
19.
Yoo, S. J.,
Shim, Y. K.,
Seong, I. S.,
Seol, J. H.,
Kang, M. S.,
and Chung, C. H.
(1997)
FEBS Lett.
412,
57-60[CrossRef][Medline]
[Order article via Infotrieve]
20.
Neuwald, A. F., Aravind, L., Spouge, J. L., and Koonin,
E. V. Genome Res. 9, 27-43
21.
Gottesman, S.,
Roche, E.,
Zhou, Y.,
and Sauer, R. T.
(1998)
Genes Dev.
12,
1338-1347 22.
Pak, M.,
Hoskins, J. R.,
Singh, S. K.,
Maurizi, M. R.,
and Wickner, S.
(1999)
J. Biol. Chem.
274,
19316-19322 23.
Seong, I. S., Oh, J. Y.,
Yoo, S. J.,
Seol, J. H.,
and Chung, C. H.
(1999)
FEBS Lett.
456,
211-214[CrossRef][Medline]
[Order article via Infotrieve]
24.
Levchenko, I.,
Luo, L.,
and Baker, T. A.
(1995)
Genes Dev.
9,
2399-2408 25.
Seong, I. S., Oh, J. Y.,
Lee, J. W.,
Tanaka, K.,
and Chung, C. H.
(2000)
FEBS Lett.
477,
224-228[CrossRef][Medline]
[Order article via Infotrieve]
26.
Weber-Ban, E. U.,
Reid, B. G.,
Miranker, A. D.,
and Horwich, A. L.
(1999)
Nature
401,
90-93[CrossRef][Medline]
[Order article via Infotrieve]
27.
Reid, B. G.,
Fenton, W. A.,
Horwich, A. L.,
and Weber-Ban, E. U
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
3768-3772 28.
Wang, J.,
Hartling, J. A.,
and Flanagan, J. M.
(1997)
Cell
91,
447-456[CrossRef][Medline]
[Order article via Infotrieve]
29.
Wang, J.,
Hartling, J. A.,
and Flanagan, J. M.
(1998)
J. Struct. Biol.
124,
151-163[CrossRef][Medline]
[Order article via Infotrieve]
30.
Gottesman, S.,
Maurizi, M. R.,
and Wickner, S.
(1997)
Cell
91,
435-438[CrossRef][Medline]
[Order article via Infotrieve]
31.
Hoskins, J. R.,
Pak, M.,
Maurizi, M. R.,
and Wickner, S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12135-12140 32.
Hochstrasser, M.,
and Wang, J.
(2001)
Nat. Struct. Biol.
8,
294-296[CrossRef][Medline]
[Order article via Infotrieve]
33.
Kim, Y. I.,
Levchenko, I.,
Fraczkowska, K.,
Woodruff, R. V.,
Sauer, R. T.,
and Baker, T. A.
(2001)
Nat. Struct. Biol.
8,
230-233[CrossRef][Medline]
[Order article via Infotrieve]
34.
Bochtler, M.,
Hartmann, C.,
Song, H. K.,
Bourenkov, G. P.,
Bartunik, H. D.,
and Huber, R.
(2000)
Nature
403,
800-805[CrossRef][Medline]
[Order article via Infotrieve]
35.
Sousa, M. C.,
Trame, C. B.,
Tsuruta, S.,
Wilbanks, S. M.,
Reddy, R. S.,
and McKay, D.
(2000)
Cell
103,
633-643[CrossRef][Medline]
[Order article via Infotrieve]
36.
Wang, J.,
Song, J. J.,
Franklin, M. C.,
Kamtekar, S., Im, Y. J.,
Rho, S. H.,
Seong, I. S.,
Lee, C. S.,
Chung, C. H.,
and Eom, S. H.
(2001)
Structure
9,
177-184[Medline]
[Order article via Infotrieve]
37.
Song, H. K.,
Hartmann, C.,
Ramachandran, R.,
Bochtler, M.,
Behrendt, R.,
Moroder, L.,
and Huber, R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
14103-14108 38.
Wang, J.,
Song, J. J.,
Seong, I. S.,
Franklin, M. C.,
Kamtekar, S.,
Eom, S. H.,
and Chung, C. H.
(2001)
Structure
9,
1107-1116[Medline]
[Order article via Infotrieve]
39.
Trame, C. T.,
and McKay, D. B.
(2001)
Acta Crystallogr. Sect. D Biol. Crystallogr.
57,
1079-1090[Medline]
[Order article via Infotrieve]
40.
Yoo, S. J.,
Seol, J. H.,
Shin, D. H.,
Rohrwild, M.,
Kang, M. S.,
Tanaka, K.,
Goldberg, A. L.,
and Chung, C. H.
(1996)
J. Biol. Chem.
271,
14035-14040 41.
Ames, B.
(1996)
Methods Enzymol.
8,
115-118
42.
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
43.
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
44.
Seol, J. H.,
Yoo, S. J.,
Shin, D. H.,
Shim, Y. K.,
Kang, M. S.,
Goldberg, A. L.,
and Chung, C. H.
(1997)
Eur. J. Biochem.
247,
1143-1150[Medline]
[Order article via Infotrieve]
45.
Holt, C.,
and Sawyer, L.
(1993)
J. Chem. Soc. Faraday Trans.
89,
2683-2692[CrossRef]
46.
Syme, C. D.,
Blanch, E. W.,
Holt, C.,
Jakes, R.,
Goedert, M.,
Hecht, L.,
and Barron, L. D.
(2002)
Eur. J. Biochem.
269,
148-156[Medline]
[Order article via Infotrieve]
47.
Bi, E.,
and Lutkenhaus, J.
(1990)
J. Bacteriol.
172,
5602-5609 48.
Yoo, S. J.,
Seol, J. H.,
Seong, I. S.,
Kang, M. S.,
and Chung, C. H.
(1997)
Biochem. Biophys. Res. Commun.
238,
581-585[CrossRef][Medline]
[Order article via Infotrieve]
49.
Groll, M.,
Bajorek, M.,
Köhler, A.,
Moroder, L.,
Rubin, D. M.,
Huber, R.,
Glickman, M. H.,
and Finley, D.
(2000)
Nat. Struct. Biol.
7,
1062-1067[CrossRef][Medline]
[Order article via Infotrieve]
50.
Whitby, F. G.,
Masters, E. I.,
Kramer, L.,
Knowlton, J. R.,
Yao, Y.,
Wang, C. C.,
and Hill, C. P.
(2000)
Nature
408,
115-120[CrossRef][Medline]
[Order article via Infotrieve]
51.
Pickart, C. M.,
and VanDemark, A. P.
(2000)
Nat. Struct. Biol.
7,
999-1001[CrossRef][Medline]
[Order article via Infotrieve]
52.
Yao, Y.,
Huang, L.,
Krutchinsky, A.,
Wong, M. L.,
Standing, K. G.,
Burlingame, A. L.,
and Wang, C. C.
(1999)
J. Biol. Chem.
274,
33921-33930 53.
Ma, C.-P.,
Slaughter, C. A.,
and DeMartino, G. N.
(1992)
J. Biol. Chem.
267,
10515-10523 54.
Dubiel, W.,
Platt, G.,
Ferrell, K.,
and Rechsteiner, M.
(1992)
J. Biol. Chem.
267,
22369-22377 55.
Realini, C.,
Jensen, C. C.,
Zhang, Z.,
Johnston, S. C.,
Knowlton, J. R.,
Hill, C. P.,
and Rechsteiner, M.
(1997)
J. Biol. Chem.
272,
25483-25492 56.
Groll, M.,
Ditzel, L.,
Lowe, J.,
Stock, D.,
Bochtler, M.,
Bartunik, H. D.,
and Huber, R.
(1997)
Nature
386,
463-471[CrossRef][Medline]
[Order article via Infotrieve]
57.
Koradi, R.,
Billeter, M.,
and Wuthrich, K.
(1996)
J. Mol. Graph.
14,
51-55[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. V. Rotanova, I. Botos, E. E. Melnikov, F. Rasulova, A. Gustchina, M. R. Maurizi, and A. Wlodawer Slicing a protease: Structural features of the ATP-dependent Lon proteases gleaned from investigations of isolated domains. Protein Sci., August 1, 2006; 15(8): 1815 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Park, Y. M. Rho, O.-j. Koh, S. W. Ahn, I. S. Seong, J.-J. Song, O. Bang, J. H. Seol, J. Wang, S. H. Eom, et al. Role of the GYVG Pore Motif of HslU ATPase in Protein Unfolding and Translocation for Degradation by HslV Peptidase J. Biol. Chem., June 17, 2005; 280(24): 22892 - 22898. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Azim, W. Goehring, H. K. Song, R. Ramachandran, M. Bochtler, and P. Goettig Characterization of the HslU chaperone affinity for HslV protease Protein Sci., May 1, 2005; 14(5): 1357 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Lee, C.-F. Chang, C.-L. Kuo, M.-C. Chen, C. H. Yu, P.-I Lin, and W. F. Wu Subunit Oligomerization and Substrate Recognition of the Escherichia coli ClpYQ (HslUV) Protease Implicated by In Vivo Protein-Protein Interactions in the Yeast Two-Hybrid System J. Bacteriol., April 15, 2003; 185(8): 2393 - 2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bordes, S. R. Wigneshweraraj, J. Schumacher, X. Zhang, M. Chaney, and M. Buck The ATP hydrolyzing transcription activator phage shock protein F of Escherichia coli: Identifying a surface that binds sigma 54 PNAS, March 4, 2003; 100(5): 2278 - 2283. [Abstract] [Full Text] [PDF] |
||||
| ||||||||